The programme is preliminary and subject to change
Tuesday 28 May
Advances in understanding atherosclerosis biology
New insights in lipoproteins biogenesis and uptake
Mahmood Hussain, USA
Mahmood Hussain, USA
New insights in the genetics of dyslipidemia
Catherine Boileau, France
Catherine Boileau, France
Recent developments in system biology to understand atherosclerosis
Johan Björkegren, Sweden
Johan Björkegren, Sweden
Translational opportunities of single-cell biology in atherosclerosis: what have we learned
Claudia Monaco, UK
Claudia Monaco, UK
Monday 27 May
Multi-organ interactions in atherogenesis
Impact of liver biology on molecular mechanisms of atherosclerosis
To be announced
To be announced
The role of immunity and inflammation in hypertension and atherosclerosis
Thomasz Guzik, UK
Thomasz Guzik, UK
Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications
Daniela Carnevale, Italy
Daniela Carnevale, Italy
Triglyceride partitioning in the adipose tissue and atherosclerosis
Sander Kersten, The Netherlands
Sander Kersten, The Netherlands
Wednesday 29 May
Precision medicine for cardiometabolic diseases: assessing individual susceptibility to ASCVD
Contribution of genetics
Pradeep Natarajan, USA
Pradeep Natarajan, USA
Contribution of imaging
Giovanna Liuzzo, Italy
Giovanna Liuzzo, Italy
Contribution of metabolomics and inflammation
Samia Mora, USA
Samia Mora, USA
"Omics" integration for individualized treatment
Erik Stroes, The Netherlands
Erik Stroes, The Netherlands
